Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 June 2019 | Story Ruan Bruwer | Photo BackpagePix
Lefébre Rademan
Lefébre Rademan, wing attack and goal attack, received seven Player of the Match awards in her last 17 matches for the Free State and the University of the Free State.

While she had an outstanding Telkom Netball League and was recognised as one of the best players, Lefébre Rademan is keen to take her game to the next level.

The 22-year-old BEd honours student at the University of the Free State captained the Free State Crinums to the third position in the league, and was named as the best shooter. Her 201 goals from 235 attempts (86% goal average) was the second highest by any shooter with more than 100 attempts.

Rademan’s four Player of the Match awards was the joint most. This followed last year’s Varsity Netball tournament where she also finished with the joint most awards for the best player in a fixture.

“Yes, I would say this has been the best form of my career. But I believe I can take it a step further. Reaching this form is something that comes over time with hard work.” 

Rotating between positions

What impressed about the South African A (2018) and SA U21 (2016 and 2017) player, was how she adapted when she was rotated between wing attack and goal attack during matches.

Although the majority of her career was as a defender (school) and wing attack (post school), goal attack was a position she always thought she would like. 

“In my first year, I used to nag our coach (Burta de Kock) to give me some playing time there. It is funny how it worked out, as I’m now playing mostly goal attack.”

She still hopes to win a couple of trophies with the Kovsie and Free State teams and said she will give her ‘absolute all’ to make the Protea team.

According to De Kock, Rademan is a hard worker with a never-give-up approach. “I can play her anywhere and she won’t let anyone down. Lefébre never takes praise for herself. She sets the example on and off court.”

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept